Hepatitis A virus antigen presentation

Hepatitis A virus antigen presentation refers to the biological pathway where Hepatitis A virus (HAV) components are processed and displayed to the immune system to elicit a protective response. This process begins when the virus or vaccine antigen is internalized by professional antigen-presenting cells, such as dendritic cells or macrophages (NCBI: Viral Antigen Processing, 2022). Within these cells, viral polyproteins are proteolytically degraded into peptides and loaded onto Major Histocompatibility Complex (MHC) class I or II molecules for surface expression. Recognition of these peptide-MHC complexes by T-cell receptors (TCRs) is essential for the induction of a robust adaptive immune response, including the activation of B-cells to produce neutralizing antibodies (StatPearls: Hepatitis A Vaccine, 2023). While the Hepatitis A virus cellular receptor 1 (HAVCR1) facilitates viral entry into host cells, the subsequent antigen presentation involves a broad array of host proteins rather than a single molecular target (UniProt: HAVCR1, 2024). This mechanism is the cornerstone of prophylactic vaccination strategies, which utilize inactivated viral particles to elicit protective immunity without causing disease. Consequently, this entry describes a physiological mechanism of immune activation rather than a discrete, druggable receptor or enzyme.

Other names

HAV antigen presentationHepatitis A immune activationMHC-mediated HAV peptide presentationImmune system via HAV viral antigen presentation

Induction of active immunity through the presentation of inactivated viral antigens to T-lymphocytes via MHC molecules, leading to B-cell activation and the production of neutralizing antibodies.